WO2019151417A1 - ウイルス抵抗性植物及びその作出方法 - Google Patents
ウイルス抵抗性植物及びその作出方法 Download PDFInfo
- Publication number
- WO2019151417A1 WO2019151417A1 PCT/JP2019/003436 JP2019003436W WO2019151417A1 WO 2019151417 A1 WO2019151417 A1 WO 2019151417A1 JP 2019003436 W JP2019003436 W JP 2019003436W WO 2019151417 A1 WO2019151417 A1 WO 2019151417A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cmv
- plant
- eif4e
- gene
- mutation
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 30
- 241000700605 Viruses Species 0.000 title description 40
- 241000724252 Cucumber mosaic virus Species 0.000 claims abstract description 202
- 241000196324 Embryophyta Species 0.000 claims abstract description 179
- 230000035772 mutation Effects 0.000 claims abstract description 76
- 101150114135 eIF4E gene Proteins 0.000 claims abstract description 75
- 101001082110 Acanthamoeba polyphaga mimivirus Eukaryotic translation initiation factor 4E homolog Proteins 0.000 claims abstract description 62
- 101001082109 Danio rerio Eukaryotic translation initiation factor 4E-1B Proteins 0.000 claims abstract description 61
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 67
- 238000012217 deletion Methods 0.000 claims description 47
- 230000037430 deletion Effects 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 39
- 210000000349 chromosome Anatomy 0.000 claims description 30
- 238000003780 insertion Methods 0.000 claims description 27
- 230000037431 insertion Effects 0.000 claims description 27
- 238000006467 substitution reaction Methods 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 9
- 238000007792 addition Methods 0.000 claims description 9
- 231100000221 frame shift mutation induction Toxicity 0.000 claims description 9
- 230000037433 frameshift Effects 0.000 claims description 9
- 108020004485 Nonsense Codon Proteins 0.000 claims description 8
- 230000037434 nonsense mutation Effects 0.000 claims description 8
- 244000061458 Solanum melongena Species 0.000 claims description 4
- 235000002597 Solanum melongena Nutrition 0.000 claims description 4
- 241000227653 Lycopersicon Species 0.000 claims 7
- 241000208292 Solanaceae Species 0.000 abstract description 4
- 230000001939 inductive effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 65
- 240000003768 Solanum lycopersicum Species 0.000 description 61
- 238000011081 inoculation Methods 0.000 description 17
- 208000024891 symptom Diseases 0.000 description 17
- 239000013598 vector Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 238000002965 ELISA Methods 0.000 description 14
- 238000009825 accumulation Methods 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 241000589158 Agrobacterium Species 0.000 description 12
- 108020005004 Guide RNA Proteins 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 12
- 108091033409 CRISPR Proteins 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 206010011831 Cytomegalovirus infection Diseases 0.000 description 10
- 241000723762 Potato virus Y Species 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 241001124076 Aphididae Species 0.000 description 7
- 238000010354 CRISPR gene editing Methods 0.000 description 7
- 108010014863 Eukaryotic Initiation Factors Proteins 0.000 description 7
- 102000002241 Eukaryotic Initiation Factors Human genes 0.000 description 7
- 108010044843 Peptide Initiation Factors Proteins 0.000 description 7
- 102000005877 Peptide Initiation Factors Human genes 0.000 description 7
- 241001533393 Potyviridae Species 0.000 description 7
- 230000014621 translational initiation Effects 0.000 description 7
- 230000009385 viral infection Effects 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 235000002566 Capsicum Nutrition 0.000 description 6
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 6
- 101800001092 Protein 3B Proteins 0.000 description 6
- 101800003106 VPg Proteins 0.000 description 6
- 101800001476 Viral genome-linked protein Proteins 0.000 description 6
- 101800001133 Viral protein genome-linked Proteins 0.000 description 6
- 238000010362 genome editing Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 241000710078 Potyvirus Species 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 238000004383 yellowing Methods 0.000 description 4
- 240000008067 Cucumis sativus Species 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 241000758706 Piperaceae Species 0.000 description 3
- 108010029485 Protein Isoforms Proteins 0.000 description 3
- 102000001708 Protein Isoforms Human genes 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 230000009261 transgenic effect Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000256593 Brachycaudus schwartzi Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 241000723996 Pepper mottle virus Species 0.000 description 2
- 241000722363 Piper Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 235000002634 Solanum Nutrition 0.000 description 2
- 241000207763 Solanum Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010459 TALEN Methods 0.000 description 2
- 241000723792 Tobacco etch virus Species 0.000 description 2
- 241000702308 Tomato yellow leaf curl virus Species 0.000 description 2
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 2
- 241000723854 Zucchini yellow mosaic virus Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 230000006658 host protein synthesis Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 230000006780 non-homologous end joining Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000010153 self-pollination Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001533357 Bymovirus Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000010071 Cucumis prophetarum Nutrition 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 101150095712 EIF(ISO)4E gene Proteins 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108060002636 Eukaryotic Initiation Factor-4E Proteins 0.000 description 1
- 102000005233 Eukaryotic Initiation Factor-4E Human genes 0.000 description 1
- 241000702463 Geminiviridae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 241000723990 Papaya ringspot virus Species 0.000 description 1
- 241001442654 Percnon planissimum Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 241000710119 Sobemovirus Species 0.000 description 1
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 1
- 101100396537 Solanum lycopersicum eIF4E1 gene Proteins 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009351 contact transmission Effects 0.000 description 1
- 238000012272 crop production Methods 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 101150101308 eIF4E1 gene Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000012194 insect media Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000010884 ion-beam technique Methods 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- DMJNNHOOLUXYBV-PQTSNVLCSA-N meropenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](C(=O)N(C)C)C1 DMJNNHOOLUXYBV-PQTSNVLCSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000009437 off-target effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000012882 rooting medium Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 235000015113 tomato pastes and purées Nutrition 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/06—Processes for producing mutations, e.g. treatment with chemicals or with radiation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/82—Solanaceae, e.g. pepper, tobacco, potato, tomato or eggplant
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/12—Processes for modifying agronomic input traits, e.g. crop yield
- A01H1/122—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- A01H1/1245—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance
- A01H1/126—Processes for modifying agronomic input traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, e.g. pathogen, pest or disease resistance for virus resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/08—Fruits
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/82—Solanaceae, e.g. pepper, tobacco, potato, tomato or eggplant
- A01H6/825—Solanum lycopersicum [tomato]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
Definitions
- CMV is composed of three-segment genomes, each forming a virus particle, and all particles and segments are infectively propagated.
- the disease caused by CMV is an important disease that exhibits severe symptoms, even if it is not limited to a translation initiation factor, until now, almost no resistance gene has been found in crops, and none in the solanaceous family. Therefore, the control of CMV relies only on the control of the vector aphid, and the creation of resistant varieties has been desired at breeding sites.
- the present inventors have created an individual having a mutation at a predetermined position of a specific homologue of eIF4E of tomato, which is a solanaceous plant, and inoculated this individual with CMV As a result, it was confirmed that it had CMV resistance over a long period of time, and the present invention was completed.
- Such a CMV resistant plant is the first report in the solanaceous family.
- the present invention relates to the following.
- CMV cucumber mosaic virus
- the CMV-resistant solanaceous plant according to [1] which is a plant of the genus Solanum.
- the present invention also relates to the following.
- [10] [1] A processed product of the CMV-resistant plant according to any one of [1] to [4].
- the method for producing a processed product according to [11] wherein the plant is tomato and the mutation step is a step of mutating the eIF4E gene on chromosome 3 of tomato.
- the base sequence corresponding to the mRNA sequence of eIF4E present on chromosome 3 of wild-type tomato is shown (SEQ ID NO: 1).
- T thymine
- U uracil
- the portion indicated by the wavy line (166 bases) is the base sequence of exon 2 (SEQ ID NO: 2), and the shaded portion is the editing target site (SEQ ID NO: 3).
- the upstream is edited from the base (A) existing 3 bases before TGG (PAM sequence) in the square frame.
- Example 5 it is the graph which confirmed CMV resistance of each T2 generation.
- the morbidity was confirmed based on the incidence by visual observation and the infection by ELISA (virus accumulation) test. Therefore, the morbidity is the sum of the incidence and infection rate.
- the numbers in parentheses indicate the number of strains used in the test.
- Example 6 it is the graph which compared the morbidity by visual observation and ELISA of T2 generation from A132-5 and A127-24 with the wild type control.
- all the strains in which the disease was confirmed were positive for ELISA, when the disease incidence and the virus infection rate were the same, only the disease incidence was shown.
- Example 6 the results of measuring the T2 generation virus accumulation degree by ELISA for several strains are shown for each strain.
- Example 7 the aphid insect medium CMV inoculation test was performed, and the results of confirming CMV resistance of the T2 generation are shown.
- the present embodiment a mode for carrying out the present invention (hereinafter also referred to as “the present embodiment”) will be described in detail.
- the present invention is not limited to the following embodiments and drawings, and can be implemented with various modifications within the scope of the gist thereof.
- the present embodiment relates to a CMV resistant solanaceous plant.
- the CMV resistant plant is a plant having the property of suppressing the growth of CMV after infection and / or the property of suppressing the expression of CMV infection symptoms.
- a virus having VPg has a high affinity between VPg and plant eIF4E, and VPg binds strongly to plant eIF4E and the viral gene uses a plant translation system.
- CMV uses such a VPg. It is thought that the infection mechanism is different from the virus possessed.
- Whether or not a certain plant is CMV resistant can be determined by, for example, infecting the plant with CMV by a conventional method, and accumulating CMV in the plant body by a known method such as ELISA or PCR, as shown in the Examples below. This can be determined by checking. It can also be determined by confirming the presence or absence of CMV infection symptoms (mosaic, yellowing, thread, hatching, gangrene, etc.) in plants infected with CMV. CMV is known to have multiple strains such as CMV-Y, CMV-O, CMV-Fny, and CMV-Nt9. Therefore, the presence or absence of symptoms can be confirmed according to the CMV strain to be infected.
- VPg is 5 'of the viral genome as in PVY.
- Viruses belonging to the genus Bymovirus and Sobemovirus which have resistance at the end, and which have been reported to have resistance due to mutations in the translation initiation factor, viruses which have been reported to have resistance due to mutations in the translation initiation factor, translation initiation factors so far Although there is no report of resistance due to mutations in, it is a compound resistance that shows resistance to geminiviridae viruses (such as tomato yellow leaf curl virus (TYLCV)), etc., which are seriously damaged in crop production including tomato It may be a sex plant.
- geminiviridae viruses such as tomato yellow leaf curl virus (TYLCV)
- the CMV-resistant plant is a plant belonging to the family Solanaceae, and is not particularly limited as long as it belongs to the Solanasaeae family, and examples include plants belonging to the genus Solanum, Nicotiana, Capsicum, and the like. More specifically, tomato, eggplant, tobacco, pepper, potato and the like can be mentioned.
- the CMV-resistant plant of the present embodiment is a plant of the genus Eggplant, more preferably a tomato, eggplant, or potato, and particularly preferably a tomato.
- the present embodiment may be a part of the CMV-resistant plant, and more specifically, organs such as fruits, shoots, stems, roots, shoots, and buds, plant tissues, pollen, seeds Etc.
- this embodiment also relates to a method for producing such a plant or part thereof, and the use of the mutant eIF4E gene of this embodiment in the production of such a plant or part thereof.
- the CMV-resistant plant in the present embodiment may be a processed product such as food. That is, the present embodiment also relates to a processed product of a CMV resistant solanaceous plant having a mutant eIF4E gene encoding an eIF4E protein that is non-functional with respect to CMV. Furthermore, this embodiment is a method for producing a processed product of a CMV resistant plant, comprising a step of mutating an eIF4E gene of a solanaceous plant, wherein the mutation encodes an eIF4E protein that is non-functional with respect to CMV. It also relates to a method that is a mutation to the mutant eIF4E gene.
- the processed product is not particularly limited, and may be a processed product for food, medical use or the like according to the type of plant.
- the CMV-resistant plant is tomato, edible processed tomatoes canned tomatoes, tomato paste, ketchup, tomato sauce, tomato soup, dried tomatoes, tomato juice, tomato powder, tomato concentrate, tomato And nutritional supplements (supplements) to be used.
- Manufacture of a processed product can be implemented using a CMV resistant plant as a raw material using a method well-known to those skilled in the art.
- the CMV resistant plant in this embodiment is a plant exhibiting CMV resistance, it may be a hogi, rootstock, or the like used for grafting.
- the present embodiment also relates to a plant cell (including callus) that can regenerate the above-mentioned CMV-resistant plant, and the plant cell is a CMV as in the CMV-resistant plant in the present embodiment. It has a mutated eIF4E gene that encodes an eIF4E protein that is non-functional for.
- the CMV resistant plant in this embodiment includes a plant obtained from such a plant cell.
- this embodiment also relates to a method for producing such a plant cell and the use of the mutant eIF4E gene of this embodiment in the production of such a plant cell.
- eIF4E is a kind of translation initiation factor in eukaryotes and has an important role in the initiation of protein synthesis.
- eIF4E constitutes the eIF4E family together with eIF (iso) 4E, and solanaceous plants are considered to have a plurality of eIF4E isoforms.
- eIF4E consists of two isoforms and is known to exist on chromosomes 2 and 3. Further, it is known that one kind of eIF (iso) 4E exists in tomato and exists on chromosome 9.
- Pepper is also known to have pvr1 and pvr2 on chromosome 4 as homologous genes of tomato eIF4E (pvr1 and pvr2 are allele-related), and as homologous genes of tomato eIF (iso) 4E, Pvr6 on chromosome 3 is known. Of these genes, it is preferable that the gene encoding eIF4E or a protein homologous thereto is non-functional with respect to CMV.
- an eIF4E protein that is non-functional with respect to CMV refers to an eIF4E protein that is not available when CMV infects and propagates in plants, or that reduces CMV infection and proliferation.
- the resistance gene may be mutated so as not to encode a protein.
- CMV infects a plant a specific eIF4E among a plurality of isoforms existing in a solanaceous plant is used.
- the gene encoding eIF4E) is mutated and encodes an eIF4E protein that is non-functional with respect to CMV, the translation of the protein required for infectious growth, which is encoded on the viral genome, does not proceed.
- CMV protein that requires interaction with eIF4E cannot function, it is considered that any one or more of CMV infection, CMV proliferation and expression of CMV infection symptoms are inhibited, resulting in a CMV resistant plant.
- the plant itself can use other homologs, or the plant itself uses a non-functional eIF4E protein for CMV Since it may be possible, it is considered that CMV resistance can be imparted without affecting the growth of the host solanaceous plant.
- all genes encoding an eIF4E protein that is functional to CMV are mutated.
- a polyploid plant such as a double diploid
- it is preferable that a plurality of genes encoding a functional eIF4E protein for CMV are all mutated to a CMV resistance gene.
- Such a CMV resistant plant may have other normal eIF4E genes as long as the gene encoding the eIF4E protein functional for CMV is mutated.
- an exogenous CMV resistance gene may be introduced, and all genes encoding the functional eIF4E protein for endogenous CMV may be deleted or destroyed.
- the CMV resistance gene in the present embodiment is a gene having a mutation in the nucleotide sequence of the eIF4E gene functional to CMV in a solanaceous plant, preferably the base of exon 2 of the eIF4E gene A gene having a mutation in the sequence. More specifically, when the solanaceous plant is a tomato, it has a mutation in the eIF4E gene on chromosome 3 of tomato, preferably a mutation in the base sequence of exon 2 (SEQ ID NO: 2), and more Preferably, the exon 2 has a mutation in the base sequence AGGGTAAATCTGATACCAGC (SEQ ID NO: 3).
- a frameshift mutation is a mutation that shifts the codon reading frame due to deletion or insertion of a base and encodes a different amino acid sequence, thereby becoming a CMV resistance gene.
- a nonsense mutation is a mutation in which a codon originally encoding an amino acid is changed to a stop codon, thereby becoming a CMV resistance gene.
- substitution, deletion, addition, and / or insertion of one or more bases changes the reading frame of amino acids encoded by bases below the mutated region.
- the eIF4E protein breaks, the structure changes, and the like, resulting in a CMV resistance gene.
- the mutation is a mutation of a base other than the third of the codon.
- the number of substitutions, deletions, additions and / or insertions is not particularly limited as long as a CMV resistance gene can be obtained. For example, 1 to 5, 1 to 3, 1 to It can be two or one.
- the mutations (a) to (d) are not alternatives.
- the mutations (a) and (b) can occur as a result of the mutations (c) and (d).
- the CMV resistance gene of the present embodiment has any one or more of a continuous or non-consecutive 9 base deletion, a continuous or non-contiguous 3 base deletion, and a frameshift mutation by 1 base insertion. Is preferred.
- the mutant eIF4E gene has a nucleotide sequence (SEQ ID NO: 2) in exon 2 of the eIF4E gene on chromosome 3 of tomato, preferably 1 in the nucleotide sequence AGGGTAAATCTGATACCAGC (SEQ ID NO: 3) in exon 2.
- the mutated eIF4E gene has a single base insertion between the 15th and 16th bases in the base sequence AGGGTAAATCTGATACCAGC (SEQ ID NO: 3) in exon 2 of the eIF4E gene on chromosome 3 of tomato ( In one embodiment, insertion of C (cytosine)); deletion of 3 bases from 16 to 18; deletion of any 9 bases from 8 to 18 (preferably, deletion of 9 bases other than 10 and 13); It may have a mutation selected from the group consisting of, and may have a mutation other than the above mutation.
- the base sequence of SEQ ID NO: 3 corresponds to the 135th to 154th bases of the base sequence of exon 2 of tomato (SEQ ID NO: 2).
- the mutated eIF4E gene is obtained by mutating the nucleotide sequence AGGGTAAATCTGATACCAGC (SEQ ID NO: 3) in exon 2 of the eIF4E gene on chromosome 3 of tomato to any one of SEQ ID NOs: 4 to 9. is there.
- the CMV resistance gene of the present embodiment may have a mutation other than the above as long as it exhibits the desired CMV resistance.
- This embodiment also relates to the use of the mutant eIF4E gene for conferring CMV resistance to solanaceous plants and the mutant eIF4E gene itself, which is a CMV resistance gene.
- the CMV resistant plant which has the said CMV resistance gene is not limited, when it divides roughly, it can obtain by the two kinds of methods illustrated below.
- Direct genome editing By direct genome editing of a plant having eIF4E functional for CMV, a mutation is introduced at a target point at a pinpoint to produce a plant having a CMV resistance gene.
- Mutant gene introduction a method combining the following (A) and (B).
- a CMV resistance gene is prepared and introduced into a plant using an appropriate promoter.
- B Among endogenous eIF4E possessed by plants, eIF4E that is functional with respect to CMV is non-functional with respect to CMV.
- the above method (1) can be carried out using a known genome editing technique using a site-specific nuclease such as CRISPR or TALEN.
- a site-specific nuclease such as CRISPR or TALEN.
- a CRISPR system can be preferably used, and a CRISPR / Cas9 system can be particularly preferably used.
- a guide RNA (sgRNA) containing a sequence of about 20 bases complementary to the target gene recognizes the target, and the Cas9 protein cleaves the double strand, which is a non-homologous end joining (NHEJ) repair pathway.
- NHEJ non-homologous end joining
- Cas protein and sgRNA Delivery of Cas protein and sgRNA to plants is carried out by methods known to those skilled in the art, for example, Agrobacterium method, standard transfection method, electroporation method, particle bombardment method, etc., through vectors encoding them. Can be used.
- a binary vector incorporating a Cas gene and sgRNA is constructed, Agrobacterium is transformed using this vector, and then a plant is transformed using this Agrobacterium.
- Cas protein and sgRNA can be delivered to plants (Friedrich Fauser et.al. The Plant Journal (2014) 79, 348-359, Ryo Osawa, Hiroshi Emo (2013) new plant breeding technology (See Kokusai Bunko-sha, etc.)
- the form of the plant transformed with Agrobacterium is not particularly limited as long as it can regenerate the plant body, and examples thereof include suspension culture cells, protoplasts, leaf sections, and callus. After eradication of Agrobacterium, the cells can be cultured in a drug according to the vector used, and a section into which the target gene is incorporated can be selected and cultured using drug resistance as an index.
- the guide RNA can be designed so that mutation can be introduced into the target site with high efficiency.
- 3 bases before a 3-base sequence called PAM sequence (when using the most common S. pyogenes-derived Cas9, NGG) is basically cleaved. Since the PAM sequence needs to be present immediately after the target sequence, the guide RNA can be designed with the upstream of the PAM sequence as the target sequence.
- FIG. 1 showing the sequence (SEQ ID NO: 1) corresponding to the mRNA of the eIF4E gene present on chromosome 3 of tomato, it is indicated by a square existing in exon 2 (the wavy line in FIG. 1; SEQ ID NO: 2).
- a guide RNA can be designed by setting a position as a PAM sequence and targeting usually 20 bases upstream of these 3 bases (SEQ ID NO: 3).
- SEQ ID NO: 3 When genome editing is directly performed on other plants of the solanaceous family, a guide RNA is selected by selecting a PAM sequence in exon 2 of a gene encoding eIF4E functional to CMV, as in the case of tomato. Design and introduce mutations into this target site to create plants with a CMV resistance gene.
- the guide RNA can be designed in consideration of the GC content. Moreover, it can design so that the nonspecific cutting
- the guide RNA when the plant is a tomato, can be designed to have a base sequence that targets a specific sequence in exon 2 of chromosome 3 (SEQ ID NO: 3).
- This method is a method in which the following steps (A) and (B) are combined.
- the order in which (A) and (B) are performed may be performed first as long as the plant does not die.
- part is the method of said (1).
- the mutant gene (A) A step of preparing a mutant gene encoding an eIF4E protein that is non-functional with respect to CMV, and introducing it into a plant using an appropriate promoter.
- the mutant gene (A) can be prepared using a technique known to those skilled in the art. For example, it can be obtained by synthesizing a base sequence having a desired mutation and amplifying it by PCR or the like. . Introduction of the produced mutant gene into a plant can also be carried out using techniques known to those skilled in the art. It can be carried out conveniently using a vector carrying a mutated gene, for example, using polyethylene glycol method, electroporation method, Agrobacterium method, particle gun method and the like. As long as it is a CMV resistance gene obtained by mutating the eIF4E gene derived from a solanaceous plant, a CMV resistance gene of another kind of plant may be introduced.
- (B) A step of making eIF4E functional with respect to CMV out of endogenous eIF4E possessed by plants non-functional with respect to CMV.
- a known method can be used as a method for introducing a mutation into a plant.
- a mutagen treatment such as ion beam or EMS can be used. It can also be carried out by genome editing techniques such as CRISPR and TALEN described above.
- CRISPR and TALEN genome editing techniques
- Regeneration of a plant body from a plant cell having a CMV resistance gene can be performed by methods known to those skilled in the art depending on the type of plant. For example, for tomato, SunHJet al., Plant Cell Physiol. 47: 426, 2006. For tobacco, see Jefferson RA RA et al., EMBO J. et al. 6: 3901, 1987, etc.
- confirming that a plant has a CMV resistance gene is obtained by inoculating CMV by a conventional method and confirming the accumulation of CMV in the plant by ELISA, PCR, etc. This can be confirmed by observing the symptoms of CMV infection.
- the CMV resistant plant of this embodiment includes these progeny and clones.
- the present embodiment further relates to a method for producing a CMV-resistant plant, further comprising a step of mutating the eIF4E gene of a solanaceous plant.
- the method can be carried out with reference to the above description concerning CMV resistant plants.
- the production method further includes a step of self-pollinating or cross-pollinating the CMV resistant plant of the present embodiment to obtain a progeny. Self-pollination or cross-pollination of plants can be performed by a known method.
- This embodiment also relates to a guide RNA and a vector containing the guide RNA for producing the CMV resistant plant.
- the sequence of the guide RNA is as described above.
- This embodiment further relates to a kit comprising the guide RNA.
- the kit can contain a site-specific nuclease and the like necessary for performing genome editing by the CRISPR system, and can be used to produce a CMV resistant plant.
- Example 1 Production of tomato in which mutation is introduced into eIF4 gene on chromosome 3 First, in the second exon (SEQ ID NO: 2) of eIF4E gene (Solyc03g005870) which is supposed to exist on chromosome 3 of tomato.
- the site recognized by sgRNA is arbitrarily set, and this 20-base long (AGGGTAAATCTGATACCAGCC (SEQ ID NO: 3)) double-stranded DNA is a restriction enzyme BbsI site in the vector pUC19_AtU6oligo (obtained from National Institute for Agrobiological Sciences) Built in.
- the base sequence corresponding to the mRNA sequence of eIF4E present on chromosome 3 of wild-type tomato is shown in FIG. 1 (SEQ ID NO: 1). In the actual RNA, T (thymine) in the figure is U (uracil).
- the cassette site containing the sgRNA sequence region was excised from this vector and constructed at the restriction enzyme I-SceI site in the binary vector pZD_OsU3gYSA_HolgerCas9_NPTII. Further, Agrobacterium LBA4404 (manufactured by Takara Bio Inc.) was transformed with this binary vector.
- the variety of tomatoes to be transformed was Manny Maker and our own variety S. Transformation of tomato using Agrobacterium was based on the method cited in general books (Transformation Protocol (Chemical Doujinshi)). That is, a cotyledon piece in which tomato seeds are sown in a sterile medium, or a sterilized cotyledon piece or main leaf piece that has been normally sown is sterilized in the aforementioned recombinant Agrobacterium culture medium (turbidity 0.1 to 1.0). It was immersed for about 10 minutes and infected with Agrobacterium.
- leaf fragments were carbenicillin (100 to 500 mg / ml), or Murashige-Skoog medium (MS medium; MS) supplemented with meropen (20 to 50 mg / ml) and kanamycin (30 to 100 mg / ml).
- MS medium Murashige-Skoog medium
- meropen 20 to 50 mg / ml
- kanamycin 30 to 100 mg / ml.
- Basic 3% sucrose, 1.5 mg / L zeatin, 1% agar and selective culture under 25 ° C. illumination (16 hours illumination / 8 hours dark).
- the callus formation was promoted from the leaf pieces by exchanging the medium by transplant passage every two weeks from about 10 days, and adventitious buds were induced by repeating the subculture.
- rooting medium (MS basic, 1.5% sucrose, 1% agar, 50-250 mg / ml carbenicillin, 20-100 mg / ml kanamycin, optionally naphthalene acetic acid (NAA) And cultured for 1 to 3 months while being subcultured every month.
- Root culture medium culture is all aseptic culture. The rooted individuals were taken out from the sterile medium and transplanted and grown in a pot medium mixed with commercially available black or red soil.
- any primer for example, primer 1 ( ATCCATCACCCAAGCAAGTTAATT (SEQ ID NO: 11)) and Primer 2 (GTCCACAAAGCTATTTTTTTCTCCC (SEQ ID NO: 12)), and for the region in Solidc09g090580, primer 3 (CCGTCGTGGAAAAAGCTATACAAAAGGAG (SEQ ID NO: 13) TGA (SEQ ID NO: 13) Amplified by PCR (KODPlusODNeo / Toyobo Co., Ltd.) Limited enzyme sites was confirmed whether cut by the restriction enzyme (data not shown).
- Example 2 CMV resistance confirmation test of mutant tomato
- an individual (T0) of the editing line was grown in an isolated greenhouse and self-pollinated to recover seeds. These seeds to be transgenic progeny (T1) were sown and the seedlings were mechanically inoculated with the CMV-Y line.
- T1 transgenic progeny
- B95 and B100 T1 seedlings which are mutant strains of eIF (iso) 4E, all inoculated with CMV showed symptoms 20 days after inoculation and showed no resistance (data not shown).
- Example 3 Sequencing of CMV resistance gene The sequence of exon 2 in the eIF4E gene in the vicinity of the eIF4E editing site of the CMV resistant T1 individual using the primers 1 and 2 described above, that is, the eIF4E gene on chromosome 3 (SEQ ID NO: The region 3 ′ from the 14th position in 2) was amplified by PCR (T100 thermal cycler, manufactured by Bio-Rad), and the amplified fragment was cloned to confirm the nucleotide sequence.
- Example 5 CMV resistance confirmation test of mutant tomato (T2 generation) 1
- the T1 individuals A127-24, A132-1 and A132-5 obtained in Example 2 were grown in an isolated greenhouse as in Example 2, and T2 seeds were collected by self-pollination. These seeds for the T2 generation were sown, and for each T2 generation, CMV-Y lines were mechanically inoculated into the number of seedling seedlings shown in parentheses in the right column of FIG.
- all of the T2 generation 16 strains from A127-24 were homozygous for one base insertion (one insertion homology).
- T32 generation 30 strains from A132-1 are 9 base deletion homo 4 strains (9 deletion homo), 9 base deletion / 3 base deletion 16 strains (9 deletion / 3 deletion) and 3 base deletion homo 10 strains (3 deletion homo) ) Edit pattern. All T2 generation 27 strains from A132-5 were 3-deficient homologs. That is, in FIG. 8, “9 missing homology” and “9 missing / 3 missing” are the T2 generation from A132-1, “3 missing homology” is the T2 generation from A132-1, and A132-5, “1 insertion homology”. "Is the T2 generation from A127-24.
- CMV resistance was confirmed by the same method as in Example 2. That is, the morbidity rate of the virus was confirmed by observing infectious symptoms and ELISA test for measuring the virus accumulation degree. The results are shown in FIG. In FIG. 8, the resistance rate is the proportion of strains that are negative for ELISA test.
- Example 6 CMV resistance confirmation test of mutant tomato (T2 generation) 2 Furthermore, using seedlings of the T2 generation of A132-5 considered to be a 3-base-deficient homozygote and A127-24 considered to be a 1-base insertion homozygous, as in Example 5, CMV-Y was mechanically inoculated to increase resistance. confirmed.
- the numbers shown in parentheses in Fig. 9-1 are the number of test strains. As a control, a non-edited (non-recombinant) wild strain (wild-type variety S) was used.
- FIG. 9-2 shows the results of measuring viral infection by ELISA assay for several strains.
- a wild strain wild-type variety S
- a wild strain not inoculated with CMV was used.
- the T2 generation from any strain including the T2 generation from A127-24 corresponding to the first insertion homolog in FIG. 8 was higher in virus resistance than the control.
- Example 7 Infectious insect inoculation test using aphids Cucumber mosaic virus (CMV) is transmitted mainly by aphids in the actual field, as well as seed transmission and contact transmission. Therefore, in addition to the mechanical inoculation test, an aphid insect inoculation test was performed and the resistance was compared with the control. First, the CMV-O strain was sucked from the infected tobacco to cause the peach aphid to acquire CMV.
- CMV Cucumber mosaic virus
- RT-PCR was performed using primers 5 and 6 and enzymes (reverse transcriptase AMV reverse transcriptase (Promega) and EXTaq polymerase (Takara Bio)). As a result, it was confirmed that the editorial line had a significantly lower morbidity and CMV resistance than the control line.
- Primer 5 GTACAGAGTTCAGGGTTGAGCG (SEQ ID NO: 15)
- Primer 6 AGCAATACTGCCCAACTCAGCTCC (SEQ ID NO: 16)
- the present invention it is possible to provide a method for producing CMV-resistant solanaceous plants and CMV-resistant plants.
- the present invention has industrial applicability mainly in the agricultural field.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Developmental Biology & Embryology (AREA)
- Environmental Sciences (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
[1]
キュウリモザイクウイルス(CMV)に対して非機能的であるeIF4Eタンパク質をコードする変異eIF4E遺伝子を有する、CMV抵抗性ナス科植物。
[2]
ナス属の植物である、[1]に記載のCMV抵抗性ナス科植物。
[3]
前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子である、[1]又は[2]に記載のCMV抵抗性植物。
[4]
前記変異eIF4E遺伝子が、エクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を有する、[1]~[3]のいずれかに記載のCMV抵抗性植物。
[5]
前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子のエクソン2の塩基配列(配列番号2)における:1塩基挿入;3塩基欠損;及び9塩基欠損からなる群から選択される変異を有する、[1]~[4]のいずれか一項に記載のCMV抵抗性植物。
[6]
前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子のエクソン2中の塩基配列AGGGTAAATCTGATACCAGC(配列番号3)における:15番目と16番目の塩基間への1塩基挿入;16~18番目の3塩基欠損;8~18番目のいずれか9塩基の欠損からなる群から選択される変異を有する、[1]~[4]のいずれか一項に記載のCMV抵抗性植物。
[7]
ナス科植物のeIF4E遺伝子を変異させる工程を含む、キュウリモザイクウイルス(CMV)抵抗性植物の作出方法であって、前記変異が、CMVに対して非機能的なeIF4Eタンパク質をコードする変異eIF4E遺伝子への変異である、方法。
[8]
前記植物がトマトであり、前記変異工程が、トマトの3番染色体上のeIF4E遺伝子を変異させる工程である、[7]に記載のCMV抵抗性植物の作出方法。
[9]
前記変異工程が、eIF4E遺伝子のエクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を導入する工程である、[7]又は[8]に記載のCMV抵抗性植物の作出方法。
[10]
[1]~[4]のいずれか一項に記載のCMV抵抗性植物の加工品。
[11]
ナス科植物のeIF4E遺伝子を変異させる工程を含む、キュウリモザイクウイルス(CMV)抵抗性植物の加工品の製造方法であって、前記変異が、CMVに対して非機能的なeIF4Eタンパク質をコードする変異eIF4E遺伝子への変異である、方法。
[12]
前記植物がトマトであり、前記変異工程が、トマトの3番染色体上のeIF4E遺伝子を変異させる工程である、[11]に記載の加工品の製造方法。
[13]
前記変異工程が、eIF4E遺伝子のエクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を導入する工程である、[11]又は[12]に記載の加工品の製造方法。
[14]
キュウリモザイクウイルス(CMV)に対して非機能的であるeIF4Eタンパク質をコードする変異eIF4E遺伝子。
[15]
ナス科植物由来である、[14]に記載の変異eIF4E遺伝子。
[16]
トマトの3番染色体上のeIF4E遺伝子由来である[14]又は[15]に記載の変異eIF4E遺伝子。
[17]
エクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を有する、[14]~[16]のいずれかに記載の前記変異eIF4E遺伝子。
[18]
トマト由来であり、トマトの3番染色体上のeIF4E遺伝子のエクソン2の塩基配列(配列番号2)における:1塩基挿入;3塩基欠損;及び9塩基欠損からなる群から選択される変異を有する、[14]~[17]のいずれかに記載の変異eIF4E遺伝子。
[19]
トマト由来であり、トマトの3番染色体上のeIF4E遺伝子のエクソン2中の塩基配列AGGGTAAATCTGATACCAGC(配列番号3)における:15番目と16番目の塩基間への1塩基挿入;16~18番目の3塩基欠損;8~18番目のいずれか9塩基の欠損からなる群から選択される変異を有する、[14]~[18]のいずれかに記載の変異eIF4E遺伝子。
[20]
CMV抵抗性ナス科植物の作出における、[14]~[19]のいずれかに記載の変異eIF4E遺伝子の使用。
[21]
ナス科植物の加工品の製造における、[1]~[6]のいずれかに記載のCMV抵抗性ナス科植物の使用。
[22]
[14]~[19]のいずれかに記載の変異eIF4E遺伝子を有する、ナス科植物の植物細胞。
[23]
[1]~[6]のいずれかに記載のCMV抵抗性ナス科植物の植物細胞の作出方法。
[24]
[1]~[6]のいずれかに記載のCMV抵抗性ナス科植物の種子の作出方法。
[25]
CMV抵抗性ナス科植物の種子の作出における、[14]~[19]のいずれかに記載の変異eIF4E遺伝子の使用。
[26]
[14]~[19]のいずれかに記載の変異eIF4E遺伝子を含む、ベクター、プロモーター又はキット。
[27]
CMV抵抗性ナス科植物、その植物細胞、その植物の種子又はその子孫の作出における、[26]記載のベクター、プロモーター又はキットの使用。
本実施形態におけるCMV抵抗性植物は、CMV抵抗性を示す植物である限り、接ぎ木に利用する穂木、台木等であってもよい。また、一態様において、本実施形態は、上述のCMV抵抗性植物を再生し得る植物細胞(カルスを含む)等にも関し、かかる植物細胞は、本実施形態におけるCMV抵抗性植物と同様、CMVに対して非機能的であるeIF4Eタンパク質をコードする変異eIF4E遺伝子を有する。本実施形態におけるCMV抵抗性植物は、このような植物細胞から得られた植物も含む。一態様において、本実施形態は、このような植物細胞の作出方法及びこのような植物細胞の作出における本実施形態の変異eIF4E遺伝子の使用にも関する。
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入。
上述のとおり、本実施形態のCMV抵抗性遺伝子は、所望のCMV抵抗性を示す限り上記以外の変異を有するものであってもよく、一態様において、例えば、eIF4E遺伝子の塩基配列と、85%以上、好ましくは90%以上、より好ましくは95%以上、さらに好ましくは98%以上、特に好ましくは99%以上の配列同一性を有する塩基配列において、上記のいずれか変異を有するものであってもよい。
(1)直接ゲノム編集:CMVに対して機能的なeIF4Eを有する植物の直接ゲノム編集により、目的とする箇所にピンポイントで変異を導入し、CMV抵抗性遺伝子を有する植物を作出する。
(2)変異遺伝子導入:下記(A)と(B)を組み合わせた方法である。(A):CMV抵抗性遺伝子を作製し、適当なプロモーターを用いて植物に導入する。(B):植物が有する内生eIF4Eのうち、CMVに対して機能的なeIF4Eを、CMVに対して非機能的なものとする。
以下、それぞれの方法について説明する。
CRISPRシステムでは、PAM配列と呼ばれる3塩基の配列(最も一般的なS.pyogenes由来Cas9を用いる場合、NGG)の3塩基前が基本的に切断される。標的配列の直後にPAM配列が存在する必要があるため、PAM配列の上流を標的配列として、ガイドRNAを設計することができる。例えば、トマトの3番染色体に存在するeIF4E遺伝子のmRNAに対応する配列(配列番号1)を示す図1中、エクソン2(図1中、波線部。配列番号2)に存在する四角で示した箇所をPAM配列とし、この3塩基から上流の通常20塩基(配列番号3)を標的としてガイドRNAを設計することができる。ナス科の他の植物に対して直接ゲノム編集を行う場合も、トマトの場合と同様に、CMVに対して機能的なeIF4Eコードする遺伝子のエクソン2の中でPAM配列を選択してガイドRNAを設計し、この標的部位に変異を導入して、CMV抵抗性遺伝子を有する植物を作出することができる。
(A)の変異遺伝子の作製は、当業者に公知の手法を用いて実施することができ、例えば、所望の変異を有する塩基配列を合成し、これをPCR等で増幅して得ることができる。作製した変異遺伝子の植物への導入も、当業者に公知の手法を用いて実施することができる。簡便には、変異遺伝子を搭載したベクターを用いて、例えば、ポリエチレングリコール法、エレクトロポレーション法、アグロバクテリウム法、パーティクルガン法等を用いて実施することができる。ナス科植物由来のeIF4E遺伝子を変異させたCMV抵抗性遺伝子であれば、別種の植物のCMV抵抗性遺伝子を導入してもよい。
(B)の実施には、植物に変異を導入する方法として公知の手法を用いることができ、例えば、イオンビーム、EMSなどの変異原処理を用いることができる。上述のCRISPRやTALENなどのゲノム編集技術等によっても実施することができる。内生eIF4Eのうち、CMVに対して機能的なeIF4Eを、全てCMVに対して非機能的なものとすることが望ましい。
まず、トマトの染色体3番に存在するとされているeIF4E遺伝子(Solyc03g005870)の2番目のエクソン(配列番号2)内にsgRNAが認識する部位を任意に設定し、この20塩基長(AGGGTAAATCTGATACCAGC(配列番号3))の二本鎖DNAをベクターpUC19_AtU6oligo(国立研究開発法人農業生物資源研究所より入手)内の制限酵素BbsIサイトに構築した。なお、野生株のトマトの3番染色体に存在するeIF4EのmRNA配列に対応する塩基配列を図1に示す(配列番号1)。実際のRNAは図中のT(チミン)がU(ウラシル)である。
次に、編集系統の個体(T0)を隔離温室内で生育し、自家受粉させて種子を回収した。トランスジェニック後代(T1)となるこれらの種子を播種し、実生苗にCMV-Y系統を機械的接種した。その結果、eIF4Eの編集系統A127及びA132のT1個体A127-8、A127-14、A127-21、A127-24、A132-1、A132-5は接種20日以上でも症状が見られなかった(図5)。また、抗CMV抗体(日本植物防疫協会より入手)を用いて、CMV接種20日以降、ウイルス蓄積度を測るELISA検定を行ったところ、非接種株と同程度のウイルス蓄積度であり、CMVの感染は確認できなかった(図2~4)。また、当該個体は接種後60日以上たっても病徴が見られず、CMV抵抗性を示していた(表2)。
前述のプライマー1及び2を用いてCMV抵抗性T1個体のeIF4E編集部位付近、すなわち、3番染色体上のeIF4E遺伝子中、エクソン2の配列(配列番号2)の14番目付近から3’側の領域をPCR(T100サーマルサイクラー、Bio-Rad社製)で増幅し、増幅断片をクローニングして塩基配列を確認した。
野生型:AGGGTAAATCTGATA・CCAGC(配列番号3)
変異1:AGGGTAAATCTGATACCCAGC(配列番号4)
変異2:AGGGTAAATCTGATA・・・・GC(配列番号5)
変異3:AGGGTAA・・C・・A・・・・・・GC(配列番号6)
変異4:AGGGTAAATGTGATA・・・・GC(配列番号7)
変異5:AGTGTAA・・C・・A・・・・・・GC(配列番号8)
変異6:AGGGTAAATGTAACA・・・・GC(配列番号9)
A132及びA143のT1種子を別に播種し、それら実生苗にPVY-N系統を接種したところ、全ての個体で接種から21日以上たっても症状やウイルスの蓄積が見られず、PVY抵抗性が確認された(図7)。
実施例2で得られたT1個体、A127-24、A132-1及びA132-5について、実施例2と同様隔離温室内で生育し、自家受粉によってT2種子を回収した。
T2世代となるこれらの種子を播種し、各T2世代につき、図8中右欄の括弧内に示す株数の実生苗にCMV-Y系統を機械的接種した。塩基配列を確認したところ、A127-24からのT2世代16株は、全て1塩基挿入ホモ(1挿ホモ)であった。A132-1からのT2世代30株は、9塩基欠損ホモ4株(9欠ホモ)、9塩基欠損/3塩基欠損16株(9欠/3欠)及び3塩基欠損ホモ10株(3欠ホモ)の編集パターンを含んでいた。A132-5からのT2世代27株は、全て3欠ホモであった。すなわち、図8中、「9欠ホモ」及び「9欠/3欠」はA132-1からのT2世代、「3欠ホモ」はA132-1及びA132-5からのT2世代、「1挿ホモ」はA127-24からのT2世代である。
さらに3塩基欠損ホモと考えられるA132-5と、1塩基挿入ホモと考えられるA127-24のT2世代の実生苗を用い、実施例5と同様、CMV―Yを機械的接種して抵抗性を確認した。図9-1中括弧内に示す数字は供試株数である。対照には、非編集(非組換え)の野生株(野生型品種S)を用いた。接種20日後、感染症状の観察により発病率を、ELISAによる検定によりウイルス感染率を調査し、総合して罹病率としてCMV抵抗性を確認した。図9-2はいくつかの株について、ウイルス感染をELISA検定で測定した結果を示す。陽性対照として、野生株(野生型品種S)にCMV接種したものを用い、陰性対照としてCMV接種をしていない野生株を用いた。その結果、図9-1に示すように、図8中、1挿ホモにあたるA127-24からのT2世代を含め、いずれの株からのT2世代も、対照に比べ、ウイルス抵抗性が高かった。
キュウリモザイクウイルス(CMV)は実圃場では、主にアブラムシによって伝搬感染するほか、種子伝染、接触伝染する。そのため、機械的接種試験に加えて、アブラムシ虫媒接種試験を行い、対照との抵抗性の比較を行った。
まず、CMV-O系統を感染させたタバコから吸汁させることにより、モモアカアブラムシにCMVを獲得させた。
対照には野生型Sの実生苗を用い、同様の条件で実施した。接種後21日から26日にかけ、症状調査とRT-PCRにより罹病率を算出した。すなわち、目視観察による発病率と、RT-PCRによる感染率を統合したものが罹病率である。
プライマー5:GTACAGAGTTCAGGGTTGAGCG(配列番号15)
プライマー6:AGCAATACTGCCAACTCAGCTCC(配列番号16)
Claims (9)
- キュウリモザイクウイルス(CMV)に対して非機能的であるeIF4Eタンパク質をコードする変異eIF4E遺伝子を有する、CMV抵抗性ナス科植物。
- ナス属の植物である、請求項1に記載のCMV抵抗性ナス科植物。
- 前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子である、請求項1又は2に記載のCMV抵抗性植物。
- 前記変異eIF4E遺伝子が、エクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を有する、請求項1~3のいずれかに記載のCMV抵抗性植物。 - 前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子のエクソン2中の塩基配列(配列番号2)における:1塩基挿入;3塩基欠損;及び9塩基欠損からなる群から選択される変異を有する、請求項1~4のいずれか一項に記載のCMV抵抗性植物。
- 前記植物がトマトであり、前記変異eIF4E遺伝子が、トマトの3番染色体上のeIF4E遺伝子のエクソン2中の塩基配列AGGGTAAATCTGATACCAGC(配列番号3)における:15番目と16番目の塩基間への1塩基挿入;16~18番目の3塩基欠損;8~18番目のいずれか9塩基の欠損からなる群から選択される変異を有する、請求項1~4のいずれか一項に記載のCMV抵抗性植物。
- ナス科植物のeIF4E遺伝子を変異させる工程を含む、キュウリモザイクウイルス(CMV)抵抗性植物の作出方法であって、前記変異が、CMVに対して非機能的なeIF4Eタンパク質をコードする変異eIF4E遺伝子への変異である、方法。
- 前記植物がトマトであり、前記変異工程が、トマトの3番染色体上のeIF4E遺伝子を変異させる工程である、請求項7に記載のCMV抵抗性植物の作出方法。
- 前記変異工程が、eIF4E遺伝子のエクソン2の塩基配列に、以下のいずれか一以上の変異:
(a)フレームシフト変異
(b)ナンセンス変異
(c)連続又は非連続の3n塩基(n=1~7)の欠損
(d)1又は複数の塩基の置換、欠失、付加、及び/又は挿入
を導入する工程である、請求項7又は8に記載のCMV抵抗性植物の作出方法。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19748249.0A EP3760037A4 (en) | 2018-02-02 | 2019-01-31 | VIRUS RESISTANT PLANT AND PROCESS FOR PRODUCING THE SAME |
CN201980011387.1A CN111683523B (zh) | 2018-02-02 | 2019-01-31 | 病毒抗性植物及其制备方法 |
JP2019569561A JP7264832B2 (ja) | 2018-02-02 | 2019-01-31 | ウイルス抵抗性植物及びその作出方法 |
KR1020207024902A KR102517095B1 (ko) | 2018-02-02 | 2019-01-31 | 바이러스 저항성 식물 및 그의 작출 방법 |
US16/963,191 US11814639B2 (en) | 2018-02-02 | 2019-01-31 | Virus-resistant plant and method for producing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018-017542 | 2018-02-02 | ||
JP2018017542 | 2018-02-02 | ||
JP2018-236352 | 2018-12-18 | ||
JP2018236352 | 2018-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019151417A1 true WO2019151417A1 (ja) | 2019-08-08 |
Family
ID=67478321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/003436 WO2019151417A1 (ja) | 2018-02-02 | 2019-01-31 | ウイルス抵抗性植物及びその作出方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US11814639B2 (ja) |
EP (1) | EP3760037A4 (ja) |
JP (1) | JP7264832B2 (ja) |
KR (1) | KR102517095B1 (ja) |
CN (1) | CN111683523B (ja) |
CL (1) | CL2020001982A1 (ja) |
WO (1) | WO2019151417A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020111149A1 (ja) * | 2018-11-28 | 2020-06-04 | キッコーマン株式会社 | トマトに黄化葉巻様症状を呈するベゴモウイルス属ウイルスに抵抗性のナス科植物、ナス科植物細胞、およびナス科植物の作出方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04330234A (ja) * | 1991-03-20 | 1992-11-18 | Japan Tobacco Inc | キュウリモザイクウィルス抵抗性トマト及びその作出方法 |
WO2017188321A1 (ja) * | 2016-04-28 | 2017-11-02 | 日本たばこ産業株式会社 | ウイルス抵抗性タバコおよびその作出方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2835698B1 (fr) * | 2002-02-08 | 2004-08-06 | Genoplante Valor | Procede de selection ou d'obtention de plantes resistantes aux potyvirus et sequences marquant ou codant cette resistance |
CA2741285C (en) * | 2008-10-22 | 2017-12-12 | Cornell University | Mutated eif4e sequences from potato which are useful in imparting virus resistance |
CN103826440A (zh) * | 2010-10-18 | 2014-05-28 | 杰.尔.辛普洛公司 | 马铃薯的马铃薯y病毒组抗性 |
JP6445006B2 (ja) * | 2014-06-27 | 2018-12-26 | 日本たばこ産業株式会社 | ウイルス抵抗性タバコおよびその作出方法 |
-
2019
- 2019-01-31 WO PCT/JP2019/003436 patent/WO2019151417A1/ja unknown
- 2019-01-31 US US16/963,191 patent/US11814639B2/en active Active
- 2019-01-31 EP EP19748249.0A patent/EP3760037A4/en active Pending
- 2019-01-31 CN CN201980011387.1A patent/CN111683523B/zh active Active
- 2019-01-31 JP JP2019569561A patent/JP7264832B2/ja active Active
- 2019-01-31 KR KR1020207024902A patent/KR102517095B1/ko active IP Right Grant
-
2020
- 2020-07-29 CL CL2020001982A patent/CL2020001982A1/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04330234A (ja) * | 1991-03-20 | 1992-11-18 | Japan Tobacco Inc | キュウリモザイクウィルス抵抗性トマト及びその作出方法 |
WO2017188321A1 (ja) * | 2016-04-28 | 2017-11-02 | 日本たばこ産業株式会社 | ウイルス抵抗性タバコおよびその作出方法 |
Non-Patent Citations (9)
Title |
---|
CHANDRASEKARAN ET AL., MOLECULAR PLANT PATHOLOGY, vol. 17, no. 7, 2016, pages 1140 - 1153 |
CHANDRASEKARAN, J. ET AL.: "Development of broad virus resistance in non-transgenic cucumber using CRISPR/Cas9 technology", MOLECULAR PLANT PATHOLOGY, vol. 17, no. 7, 2016, pages 1140 - 1153, XP055485226, doi:10.1111/mpp.12375 * |
FRIEDRICH FAUSER ET AL., THE PLANT JOURNAL, vol. 79, 2014, pages 348 - 359 |
JEFFERSON RA ET AL., EMBO J., vol. 6, 1987, pages 3901 |
MAZIER ET AL., PLOS ONE, vol. 6, 2011, pages e29595 |
OHSAWA, RYOEZURA, HIROSHI: "NBT (new plant breeding techniques", 2013, INTERNATIONAL ACADEMIC PUBLISHING CO., LTD. |
RODRIGUEZ-HERNANDEZ, A.M. ET AL.: "Melon RNA interference (RNAi) lines silenced for Cm-eIF4E show broad virus resistance", MOLECULAR PLANT PATHOLOGY, vol. 13, no. 7, 2012, pages 755 - 763, XP055597162, doi:10.1111/j.1364-3703.2012.00785.x * |
SATO ET AL., FEBS LETT., vol. 579, no. 5, 2005, pages 1167 - 1171 |
SUN HJ ET AL., PLANT CELL PHYSIOL., vol. 47, 2006, pages 426 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020111149A1 (ja) * | 2018-11-28 | 2020-06-04 | キッコーマン株式会社 | トマトに黄化葉巻様症状を呈するベゴモウイルス属ウイルスに抵抗性のナス科植物、ナス科植物細胞、およびナス科植物の作出方法 |
EP3888452A4 (en) * | 2018-11-28 | 2023-02-08 | Kikkoman Corporation | SOLANACEOUS PLANT RESISTANT TO VIRUS OF THE GENUS BEGOMOVIRUS CAUSING THE SYMPTOMS OF CURLING YELLOW LEAVES OF TOMATO, SOLANACEOUS PLANT CELL AND METHOD FOR PRODUCING A SOLANACEOUS PLANT |
Also Published As
Publication number | Publication date |
---|---|
EP3760037A4 (en) | 2021-12-08 |
KR20200112957A (ko) | 2020-10-05 |
US20210123071A1 (en) | 2021-04-29 |
CN111683523A (zh) | 2020-09-18 |
EP3760037A1 (en) | 2021-01-06 |
JPWO2019151417A1 (ja) | 2021-01-14 |
CN111683523B (zh) | 2023-07-14 |
JP7264832B2 (ja) | 2023-04-25 |
CL2020001982A1 (es) | 2021-01-29 |
US11814639B2 (en) | 2023-11-14 |
KR102517095B1 (ko) | 2023-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6702957B2 (ja) | タバコ植物における腋芽成長の遺伝的制御法 | |
JP7015243B2 (ja) | 吸枝が減少又は消失したタバコ植物及びタバコ製品を生産する組成物及び方法 | |
US20220403409A1 (en) | CCA Gene For Virus Resistance | |
Huang et al. | Transgenic watermelon lines expressing the nucleocapsid gene of Watermelon silver mottle virus and the role of thiamine in reducing hyperhydricity in regenerated shoots | |
Dunemann et al. | Using CRISPR/Cas9 to produce haploid inducers of carrot through targeted mutations of centromeric histone H3 (CENH3) | |
CN113163728B (zh) | 菜豆金色花叶病毒属病毒抗性番茄细胞的制作方法 | |
ES2627863B1 (es) | Composiciones y métodos para determinar la alimentación por psílidos | |
WO2019103034A1 (ja) | ゲノム編集植物の生産方法 | |
WO2019151417A1 (ja) | ウイルス抵抗性植物及びその作出方法 | |
Schaart et al. | Novel plant breeding techniques. Consequences of new genetic modification-based plant breeding techniques in comparison to conventional plant breeding | |
WO2021129895A2 (zh) | 侵染性植物弹状病毒载体及无转基因植物基因组定点编辑的方法 | |
WO2021131628A1 (ja) | トマト黄化えそウイルス抵抗性のナス科植物、ナス科植物細胞、及びナス科植物の作出方法 | |
WO2022186197A1 (ja) | トマトに黄化葉巻様症状を呈するベゴモウイルス属ウイルスに抵抗性のナス科植物、ナス科植物細胞、およびナス科植物の作出方法 | |
CN114828621B (zh) | 番茄斑萎病毒抗性番茄细胞的制作方法 | |
JP2021507691A (ja) | ジェミニウイルス抵抗性植物 | |
Fermin et al. | Papaya: engineering resistance against papaya ringspot virus by native, chimeric and synthetic transgenes | |
Schaart et al. | Novel plant breeding techniques | |
EP4186917A1 (en) | Tobamovirus resistant plants | |
JP2024054422A (ja) | 感染性植物ラブドウイルスベクターおよび植物における非トランスジェニックのゲノム部位特異的編集の方法 | |
WO2024023207A1 (en) | Eif(iso)4e protein variants for resistance to maize viral diseases | |
Gomez | CRISPR-Mediated Susceptibility Gene Editing and Viral Interference for Plant Disease Resistance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19748249 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019569561 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207024902 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019748249 Country of ref document: EP Effective date: 20200902 |